Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ReposiTrak's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ReposiTrak's regulatory disclosures and financial reporting.
ReposiTrak (TRAK) Form 4: CEO, Chairman & 10% owner Randall K. Fields disclosed the automatic sale of 7,500 common shares on 7/28-7/30/2025 under a pre-arranged Rule 10b5-1 plan enacted to fund charitable commitments. Sales were executed by the 2022 RK Fields Charitable LLC at VWAPs of $18.27, $18.10 and $17.11, generating roughly $135k gross proceeds.
After the transactions, the charitable LLC still holds 124,500 shares. Including other direct and indirect holdings, Fields retains significant ownership:
- Direct: 3,683,955 common shares
- Indirect: 615,260 (Riverview Financial Corp.), 333,643 (Fields Management Inc.), 30,667 (spouse)
- Series B preferred: 543,754 indirect cumulative
No derivative activity or option exercises were reported. The filing signals modest insider selling (≈0.16% of reported common holdings) rather than a major ownership reduction, and the 10b5-1 structure limits discretionary market timing.
ReposiTrak (NASDAQ:TRAK) filed a routine Form 4 on 06/25/2025 disclosing CEO/Chair Randall K. Fields’ automatic Rule 10b5-1 sales of 7,500 common shares for about $150k in aggregate, leaving him with roughly 4.8 million shares across direct and indirect holdings. No change to control or overall ownership percentage.
ReposiTrak CEO Randall K. Fields reported multiple stock sales executed through a Rule 10b5-1 trading plan via his charitable LLC. The transactions occurred over three consecutive days:
- June 16, 2025: Sold 1,500 shares at avg. price of $20.53
- June 17, 2025: Sold 3,500 shares at avg. price of $20.16
- June 18, 2025: Sold 2,500 shares at avg. price of $20.38
Following these transactions, Fields maintains significant holdings: 3,683,955 shares directly owned and substantial indirect ownership through various entities including 615,260 shares via Riverview Financial Corp. The sales were executed to meet charitable commitments. Fields holds multiple roles as Director, 10% Owner, and CEO. Additionally, he has indirect beneficial ownership of Series B Preferred Stock through Riverview Financial Corp (531,432 shares) and his spouse (12,322 shares).